SkinMedica Inc., An Allergan Company

SkinMedica Inc., An Allergan Company, founded in 1999, is a biotechnology company based in the United States. The company's mission, as described in its description, is to provide naturally radiant skin through advanced skincare products developed after years of research. Their product line is centered around the science of skin healing, targeting issues such as decreased elasticity and overall aging. With a focus on scientific recovery compounds, like vitamins C and E, retinol, and their patented TNS® blend, SkinMedica's products have shown proven results in reducing fine lines, age spots, and improving skin texture and elasticity. The company's last investment was a significant $16.75M Venture Round investment on 06 January 2012. This demonstrates investor confidence in SkinMedica's scientific approach to skincare. The absence of specific investor names for the last investment indicates the potential for a wider range of investor interest. Overall, SkinMedica Inc.'s commitment to scientific research and development, as well as their proven track record in skincare innovation, makes them an attractive prospect for venture capital investment. Their focus on creating a lifelong skincare solution aligns with the current trends towards health and wellness, further enhancing their potential for growth and future investment opportunities.